CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Daniele Passarella

OPENALEX: A5051114446↗ORCID: 0000-0001-6180-9581↗

Affiliations

Organizations

University of Milanauthorship · IT

Public evidence

4 connected articles

Cannabizetol, a Novel Cannabinoid: Chemical Synthesis, Anti-inflammatory Activity and Extraction from <i>Cannabis sativa</i> L.2025 · Europe PMC Self-Assembled Cannabigerol-Based Nanoparticles: Design, Synthesis, and Antiproliferative Activity.2025 · Europe PMC Cannabidiol as Self-Assembly Inducer for Anticancer Drug-Based Nanoparticles.2022 · PubMed Central Open Access Cannabidiol as the Substrate in Acid-Catalyzed Intramolecular Cyclization.2020 · Europe PMC

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 08/09/2026.

Daniele Passarella - Medical Cannabis Research Engine